Lenalidomide therapy in treatment refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare

BACKGROUND: Lenalidomide is a thalidomide analogue that may serve as an adjunctive therapy for treatment refractory cutaneous lupus erythematosus (CLE). OBJECTIVES: We evaluate the use of lenalidomide in CLE and describe the skin and circulating leukocyte profile of treatment refractory patients bef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Braunstein, I, Goodman, NG, Rosenbach, M, Okawa, J, Shah, A, Krathen, M, Kovarik, CL, Luning Prak, E, Werth, VP
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306524/
https://ncbi.nlm.nih.gov/pubmed/21821308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2011.01.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados